GB0520368D0 - Antibacterial pyrrols - Google Patents

Antibacterial pyrrols

Info

Publication number
GB0520368D0
GB0520368D0 GBGB0520368.2A GB0520368A GB0520368D0 GB 0520368 D0 GB0520368 D0 GB 0520368D0 GB 0520368 A GB0520368 A GB 0520368A GB 0520368 D0 GB0520368 D0 GB 0520368D0
Authority
GB
United Kingdom
Prior art keywords
pyrrols
antibacterial
antibacterial pyrrols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0520368.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aston University
Original Assignee
Aston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aston University filed Critical Aston University
Priority to GBGB0520368.2A priority Critical patent/GB0520368D0/en
Publication of GB0520368D0 publication Critical patent/GB0520368D0/en
Priority to EP06794664A priority patent/EP1940390A2/en
Priority to CA002624501A priority patent/CA2624501A1/en
Priority to PCT/GB2006/003713 priority patent/WO2007039749A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/456—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0520368.2A 2005-10-06 2005-10-06 Antibacterial pyrrols Ceased GB0520368D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0520368.2A GB0520368D0 (en) 2005-10-06 2005-10-06 Antibacterial pyrrols
EP06794664A EP1940390A2 (en) 2005-10-06 2006-10-06 Antibacterial pyrrols
CA002624501A CA2624501A1 (en) 2005-10-06 2006-10-06 Antibacterial pyrrols
PCT/GB2006/003713 WO2007039749A2 (en) 2005-10-06 2006-10-06 Antibacterial pyrrols

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0520368.2A GB0520368D0 (en) 2005-10-06 2005-10-06 Antibacterial pyrrols

Publications (1)

Publication Number Publication Date
GB0520368D0 true GB0520368D0 (en) 2005-11-16

Family

ID=35429943

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0520368.2A Ceased GB0520368D0 (en) 2005-10-06 2005-10-06 Antibacterial pyrrols

Country Status (4)

Country Link
EP (1) EP1940390A2 (en)
CA (1) CA2624501A1 (en)
GB (1) GB0520368D0 (en)
WO (1) WO2007039749A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
JP5210598B2 (en) * 2007-11-06 2013-06-12 花王株式会社 Autoinducer-2 inhibitor and preventive and / or therapeutic agent for infectious diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1559600A (en) * 1966-04-23 1969-03-14 Fujisawa Pharm Co PROCESS FOR MANUFACTURING DERIVATIVES OF 2-PHENYL MALEIMIDE AND SUCCINIMIDE
US3337584A (en) * 1967-01-06 1967-08-22 Squibb & Sons Inc N-substituted maleimide compounds
DE1770042A1 (en) * 1968-03-23 1971-04-08 Basf Ag Process for the preparation of alpha, ss-dihalo-gamma-hydroxycrotone lactams
DE1770041A1 (en) * 1968-03-23 1971-09-16 Basf Ag Process for the preparation of alpha-amino-maleimides
US3816451A (en) * 1971-11-02 1974-06-11 Abbott Lab Maleimide derivatives as plant growth regulators
US3890270A (en) * 1974-04-10 1975-06-17 Tenneco Chem Polyvinyl halide resin compositions
HU175454B (en) * 1977-07-25 1980-08-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new saturated and partly saturated n-acyl-pyrrol-2,5-dion derivatives
DE3222152A1 (en) * 1982-06-12 1983-12-15 Bayer Ag, 5090 Leverkusen SUBSTITUTED MALEINIC ACID IMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PEST CONTROL
JPS5931702A (en) * 1982-08-16 1984-02-20 Earth Chem Corp Ltd Repellent composition against noxious insect and acarid
JP2752106B2 (en) * 1987-10-26 1998-05-18 株式会社片山化学工業研究所 Industrial disinfectant and disinfection method
JPH0822858B2 (en) * 1988-05-24 1996-03-06 寶酒造株式会社 Novel antibiotic H9 and method for producing the same
JPH05294952A (en) * 1992-04-16 1993-11-09 Wakamoto Pharmaceut Co Ltd Antibiotic substance wap-4068, its derivative and production thereof
JPH10316510A (en) * 1997-05-14 1998-12-02 Nissan Chem Ind Ltd N-0194 and its production
AU739140B2 (en) * 1998-05-05 2001-10-04 Astrazeneca Ab Mycobacterial inhibitors
JP4776108B2 (en) * 2001-07-03 2011-09-21 日本エンバイロケミカルズ株式会社 Industrial microbial control agent
JP3835609B2 (en) * 2003-02-05 2006-10-18 曽田香料株式会社 Melanin production inhibitor
JP2005218320A (en) * 2004-02-03 2005-08-18 Ajinomoto Co Inc New antifungal agent fa424a(n), fa424a(o), fa424b and fa424d
US7109232B2 (en) * 2004-03-08 2006-09-19 Simpson Biotech Co., Ltd. Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity

Also Published As

Publication number Publication date
WO2007039749A3 (en) 2008-05-08
WO2007039749A2 (en) 2007-04-12
EP1940390A2 (en) 2008-07-09
CA2624501A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
EP1846411A4 (en) Antibacterial agents
GB2440699B (en) Combination dolly-pallet
EP1846417A4 (en) Antibacterial agents
EP1846418A4 (en) Antibacterial agents
IL185899A0 (en) Antibacterial amide-macrocycles v
EP1845995A4 (en) Antibacterial agents
EP1846416A4 (en) Antibacterial agents
GB0624980D0 (en) Modification
GB0523041D0 (en) Combination
GB0523040D0 (en) Combination
GB0520368D0 (en) Antibacterial pyrrols
EP1962864A4 (en) Antibacterial agents
GB0513553D0 (en) Rab3a
GB0525383D0 (en) Eco-Gloo
AU3393P (en) Breakwell xTriticosecale
EG25493A (en) Pedal-scooter
AU3621P (en) Scacover Scaevola aemula
AU3292P (en) DP303 Dianella prunina
GB0411351D0 (en) Antibacterial compounds
ZA200607933B (en) Signalling
GB0525648D0 (en) Modification
GB0506838D0 (en) Concept seven
GB0523160D0 (en) Combination
GB0508237D0 (en) Combination
AU305159S (en) Ballpen

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)